Zealand Pharma and OTR Therapeutics Seal $2.5 Billion Metabolic Disease Partnership
OTR Therapeutics announced a strategic collaboration and licensing agreement with Zealand Pharma A/S (NASDAQ: ZEAL)...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity